107 related articles for article (PubMed ID: 9775151)
1. [New macrolides].
Lecomte F; Benhamou D
Rev Med Interne; 1998 Apr; 19(4):255-61. PubMed ID: 9775151
[TBL] [Abstract][Full Text] [Related]
2. [New macrolides].
Portier H; Buisson M; Chavanet P
Rev Prat; 1994 Jun; 44(12):1629-34. PubMed ID: 7939238
[TBL] [Abstract][Full Text] [Related]
3. [Macrolides. New therapeutic prospects].
Bryskier A; Labro MT
Presse Med; 1994 Dec; 23(38):1762-6. PubMed ID: 7831266
[TBL] [Abstract][Full Text] [Related]
4. In vitro activity of cethromycin, a novel antibacterial ketolide, against Chlamydia pneumoniae.
Miyashita N; Fukano H; Yoshida K; Niki Y; Matsushima T
J Antimicrob Chemother; 2003 Sep; 52(3):497-9. PubMed ID: 12917246
[TBL] [Abstract][Full Text] [Related]
5. Comparison of macrolide antibiotics.
Williams JD; Sefton AM
J Antimicrob Chemother; 1993 Mar; 31 Suppl C():11-26. PubMed ID: 8478301
[TBL] [Abstract][Full Text] [Related]
6. Azithromycin: a new 15-membered macrolide.
Treadway G
Jpn J Antibiot; 2001 Feb; 54 Suppl A():70-6. PubMed ID: 11296412
[TBL] [Abstract][Full Text] [Related]
7. The macrolides: erythromycin, clarithromycin, and azithromycin.
Alvarez-Elcoro S; Enzler MJ
Mayo Clin Proc; 1999 Jun; 74(6):613-34. PubMed ID: 10377939
[TBL] [Abstract][Full Text] [Related]
8. [Meta-analysis of randomized trials of antimicrobial drugs in the treatment of coronary heart disease].
Skochko OV; Kaĭdashev IP
Lik Sprava; 2012; (5):72-86. PubMed ID: 23534274
[TBL] [Abstract][Full Text] [Related]
9. The new macrolides: expanding the ways in antibiotic treatment.
Avilés Santa ML; Ramírez-Ronda CH
Bol Asoc Med P R; 1992 Jan; 84(1):21-5. PubMed ID: 1503585
[TBL] [Abstract][Full Text] [Related]
10. Clinical use of the new macrolides, azalides, and streptogramins in pediatrics.
Adam D
J Chemother; 1992 Dec; 4(6):371-5. PubMed ID: 1337554
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results.
Biedenbach DJ; Jones RN; Lewis MT; Croco MA; Barrett MS
Diagn Microbiol Infect Dis; 1999 Apr; 33(4):275-82. PubMed ID: 10212755
[TBL] [Abstract][Full Text] [Related]
12. [Infections with Chlamydia pneumoniae, Helicobacter pylori or cytomegalovirus and atherosclerosis].
Grabczewska Z; Nartowicz E
Przegl Lek; 1999; 56(9):584-7. PubMed ID: 10695364
[TBL] [Abstract][Full Text] [Related]
13. [Comparative in vitro activity of new oral macrolides against Streptococcus pyogenes strains].
Prado V; Romero J; Herrera N; Marinkovic K; Bustos R
Rev Med Chil; 1993 Oct; 121(10):1128-34. PubMed ID: 8191116
[TBL] [Abstract][Full Text] [Related]
14. Chlamydia pneumoniae pneumonia: role of new macrolides.
Blasi F; Cosentini R; Tarsia P; Camusso L; Campi E; Arosio C; Allegra L
J Chemother; 1995 Nov; 7 Suppl 4():117-8. PubMed ID: 8904128
[No Abstract] [Full Text] [Related]
15. Synthesis and antimicrobial evaluation of dirithromycin (AS-E 136; LY237216), a new macrolide antibiotic derived from erythromycin.
Counter FT; Ensminger PW; Preston DA; Wu CY; Greene JM; Felty-Duckworth AM; Paschal JW; Kirst HA
Antimicrob Agents Chemother; 1991 Jun; 35(6):1116-26. PubMed ID: 1929252
[TBL] [Abstract][Full Text] [Related]
16. [Macrolides: indications in 1997].
Bouhour D; Peyramond D
Presse Med; 1997 Mar; 26 Suppl 2():22-6. PubMed ID: 9113049
[TBL] [Abstract][Full Text] [Related]
17. [Macrolides: pharmacology and clinical use].
Draganov V; Nikolov R; Lazarov S
Vutr Boles; 2000; 32(4):13-7. PubMed ID: 11688325
[TBL] [Abstract][Full Text] [Related]
18. Dirithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic efficacy.
Brogden RN; Peters DH
Drugs; 1994 Oct; 48(4):599-616. PubMed ID: 7528132
[TBL] [Abstract][Full Text] [Related]
19. Clinical relevance of intracellular and extracellular concentrations of macrolides.
Carbon C
Infection; 1995; 23 Suppl 1():S10-4. PubMed ID: 7782109
[TBL] [Abstract][Full Text] [Related]
20. [Antibiotic resistance of Helicobacter pylori in children and macrolide-resistant genotypes in Helicobacter pylori].
Guo S; He L; Zhang J; Zhou L; Ding Z; Zhang J; Yu F; Wang G; Zhou J; Guan D; Ji W; Xu X
Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(8):563-6. PubMed ID: 24762681
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
